此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Validation of Population Characteristics and Dosage Prescriptions for Cognitive Function Intervention Benefits of Different Doses of Tai Chi in Elderly Patients With Mild Cognitive Impairment: A Real-World Cross-Sectional Study

2026年5月24日 更新者:Lidian Chen

Real-World External Validation Study on Beneficiary Population Characteristics and Individualized Dose Prescription for Cognitive Improvement of Tai Chi Intervention in Elderly Patients With Mild Cognitive Impairment

This is a companion real-world external validation study of two pre-registered parent randomized controlled trials (RCTs, protocol IDs: FujianUTCM-1 and FujianUTCM-2). We aim to validate the generalizability and clinical applicability of a pre-developed machine learning prediction model (for Tai Chi intervention cognitive benefit population characteristics and individualized dose prescription) in a real-world community-dwelling population.

研究概览

详细说明

Mild Cognitive Impairment (MCI) represents a critical early intervention window for delaying the onset and progression of dementia, and early non-pharmacological intervention has become an international consensus in this field. Our research team has completed two multicenter interventional randomized controlled trials (RCTs) pre-registered on ClinicalTrials.gov and their companion multicenter RCTs. Both studies adopted the standardized 24-form simplified Tai Chi as the intervention, with highly unified intervention procedures, movement specifications, and dose settings. These trials confirmed the dose-response relationship of Tai Chi intervention on cognitive improvement in older adults with MCI due to Alzheimer's disease, and preliminarily clarified the intervention effects of different Tai Chi dose combinations on patients' global cognition and cognitive subdomains.

On this basis, we will further identify the core characteristics of the population with significant cognitive benefits from Tai Chi intervention through machine learning algorithms. Based on data mining from 890 RCT participants, we will construct a dual-function machine learning prediction model for "beneficiary population identification + individualized Tai Chi dose prescription formulation". However, the above conclusions are all derived from standardized RCT settings, and their generalizability and clinical applicability in real-world community settings have not yet been validated.

As a sequential validation study, this research will conduct a cross-sectional survey by enrolling 150 older adults with long-term regular Tai Chi practice from communities in Fuzhou, China, to complete two-dimensional external validation of the previous RCT findings: to verify the consistency and feasibility between the beneficiary population characteristics and corresponding Tai Chi dose prescriptions mined from the parent RCTs, and the real Tai Chi dose combinations of the beneficiary population in the real world.

This study will form a closed loop from "causal evidence mining in RCTs" to "clinical application validation in real-world settings", and provide direct, high-level scientific evidence for the clinical promotion and individualized application of Tai Chi intervention in older adults with MCI.

研究类型

观察性的

注册 (估计的)

150

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

取样方法

非概率样本

研究人群

This cross-sectional real-world external validation study will enroll 150 community-dwelling older adults aged 60 years and above, who are diagnosed with Mild Cognitive Impairment (MCI) and have regular practice of standardized 24-form simplified Tai Chi for at least 6 months (consistent with the form used in the parent RCTs). Eligible participants will be recruited from communities in Fuzhou, China, to validate the generalizability and clinical applicability of a pre-developed machine learning prediction model for Tai Chi cognitive benefit population identification.

描述

Inclusion Criteria:

  • 1. Presence of mild cognitive impairment, not demented; 2. Age ≥ 60 years old; 3.Regular practice of standardized 24-form simplified Tai Chi for at least 6 months (consistent with the form used in the parent randomized controlled trials [RCTs]) ; 4.Informed consent and voluntary participation.

Exclusion Criteria:

  1. Geriatric Depression Scale score ≥ 9 points
  2. Cognitive impairment caused by other reasons, taking drugs, poisoning, etc;
  3. Suffer from severe musculoskeletal system diseases and other contraindications to exercise and are not suitable for Tai Chi training, such as those who suffer from stroke, Parkinson's disease, and have a history of lower limb arthritis, hip and knee joint replacement, etc;
  4. Patients with severe heart, liver, kidney failure, malignant tumors, and other major diseases;
  5. Individuals with visual/auditory impairments, writing/reading impairments, illiteracy, etc. that affect training and evaluation;
  6. Individuals with uncontrolled hypertension (systolic blood pressure greater than 160mmHg or diastolic blood pressure greater than 100mmHg after medication);
  7. Participating in other experiments that influence this study. -

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
干预/治疗
Cross-Sectional External Validation Cohort

This is the only study population for this cross-sectional observational real-world external validation study. The cohort consists of community-dwelling older adults aged 60 years and above, who are diagnosed with Mild Cognitive Impairment (MCI) and have long-term regular Tai Chi practice. Participants will be recruited from communities in Fuzhou, China, with a planned sample size of 150 participants.

This study will conduct a single time-point cross-sectional survey on this population, with no prospective follow-up. The sole objective is to externally validate the generalizability and clinical applicability of a pre-developed machine learning prediction model (for identifying MCI populations who gain significant cognitive benefits from Tai Chi intervention and formulating individualized Tai Chi dose prescriptions) in a real-world community setting.

This is the core observational exposure factor of this cross-sectional real-world external validation study, NOT an intervention actively assigned, implemented or manipulated by the investigator. This study only observes and records the existing long-term regular Tai Chi practice behavior (including dose, frequency and duration) of enrolled older adults with Mild Cognitive Impairment (MCI) during a single time-point cross-sectional survey, for the sole purpose of externally validating the generalizability of a pre-developed machine learning prediction model for Tai Chi cognitive benefit population identification and individualized dose prescription. No active behavioral intervention will be administered to any participant in this study.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Montreal Cognitive Assessment
大体时间:Single cross-sectional assessment at the time of study enrollment (baseline visit)
Global cognition
Single cross-sectional assessment at the time of study enrollment (baseline visit)

次要结果测量

结果测量
措施说明
大体时间
Wechsler Memory Scale
大体时间:Single cross-sectional assessment at the time of study enrollment (baseline visit)
Memory function
Single cross-sectional assessment at the time of study enrollment (baseline visit)
Digital Symbol test
大体时间:Single cross-sectional assessment at the time of study enrollment (baseline visit)
Attention
Single cross-sectional assessment at the time of study enrollment (baseline visit)
Trial Making Test part B
大体时间:Single cross-sectional assessment at the time of study enrollment (baseline visit)
Executive function
Single cross-sectional assessment at the time of study enrollment (baseline visit)
Stroop color word test
大体时间:Single cross-sectional assessment at the time of study enrollment (baseline visit)
Processing speed
Single cross-sectional assessment at the time of study enrollment (baseline visit)
Boston naming test
大体时间:Single cross-sectional assessment at the time of study enrollment (baseline visit)
Verbal fluency
Single cross-sectional assessment at the time of study enrollment (baseline visit)
Rey-Osterrieth complex graphics test
大体时间:Single cross-sectional assessment at the time of study enrollment (baseline visit)
Single cross-sectional assessment at the time of study enrollment (baseline visit)
Rey Auditory Verbal Learning Test
大体时间:Single cross-sectional assessment at the time of study enrollment (baseline visit)
Episodic memory
Single cross-sectional assessment at the time of study enrollment (baseline visit)

其他结果措施

结果测量
措施说明
大体时间
Blood glucose metabolism index
大体时间:Single cross-sectional assessment at the time of study enrollment (baseline visit)
fasting blood glucose
Single cross-sectional assessment at the time of study enrollment (baseline visit)
Blood lipid metabolism index
大体时间:Single cross-sectional assessment at the time of study enrollment (baseline visit)
total cholesterol (TC), total triglyceride (TG), low density lipoprotein (LDL), high density lipoprotein (HDL)
Single cross-sectional assessment at the time of study enrollment (baseline visit)
Resting-State Functional Magnetic Resonance Imaging: Default Mode Network Functional Connectivity Structural Magnetic Resonance Imaging: Hippocampal Volume
大体时间:Single cross-sectional assessment at the time of study enrollment (baseline visit)

Resting-State Functional Magnetic Resonance Imaging (rs-fMRI) Measurement of Default Mode Network Functional Connectivity Strength Resting-state fMRI (rs-fMRI) data will be acquired using a 3.0T scanner to evaluate default mode network (DMN) functional connectivity strength, a key correlate of cognitive function. All scanning parameters, preprocessing and analysis methods are identical to our parent randomized controlled trials (FujianUTCM-1/2). Data processing uses SPM12 and CONN toolbox.

3.0T Three-Dimensional T1-Weighted Structural MRI (sMRI) Measurement of Bilateral Hippocampal Total Volume 3D T1-weighted structural MRI (sMRI) data will be acquired using a 3.0T scanner to quantify bilateral hippocampal total volume. All scanning parameters, preprocessing and volumetric analysis methods are consistent with our parent randomized controlled trials (FujianUTCM-1/2). Automated segmentation uses FreeSurfer 7.4.1 with manual visual correction.

Single cross-sectional assessment at the time of study enrollment (baseline visit)
Core Peripheral Blood Biomarkers for Mild Cognitive Impairment (MCI)
大体时间:Single cross-sectional assessment at the time of study enrollment (baseline visit)
Amyloid-beta(Aβ)、phosphorylated tau(p-tau)、Neurofilament light chain(NfL)、Glial fibrillary acidic protein(GFAP)
Single cross-sectional assessment at the time of study enrollment (baseline visit)
Pittsburgh Sleep Quality Index, PSQI
大体时间:Single cross-sectional assessment at the time of study enrollment (baseline visit)
Sleep Quality
Single cross-sectional assessment at the time of study enrollment (baseline visit)
12-Item Short Form Health Survey
大体时间:Single cross-sectional assessment at the time of study enrollment (baseline visit)
General health
Single cross-sectional assessment at the time of study enrollment (baseline visit)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年5月15日

初级完成 (估计的)

2027年3月31日

研究完成 (估计的)

2027年3月31日

研究注册日期

首次提交

2026年3月27日

首先提交符合 QC 标准的

2026年5月24日

首次发布 (实际的)

2026年5月27日

研究记录更新

最后更新发布 (实际的)

2026年5月27日

上次提交的符合 QC 标准的更新

2026年5月24日

最后验证

2026年4月1日

更多信息

与本研究相关的术语

其他研究编号

  • FujianUTCM-2026-001

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅